Skip to content
10-Q

Quarterly Report

SOC TELEMED, INC.

0001213900-21-042035

← back to feed
Filed
Aug 12, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Aug 10, 2021 100.11M sh
Shares Diluted Q2 2021 · Jun 30, 2021 89.7M sh
Shares Diluted Q2 2021 · Jun 30, 2021 83.74M sh
Shares Diluted Q2 2021 · Jun 30, 2020 34.35M sh
Shares Diluted Q2 2021 · Jun 30, 2020 34.35M sh
Capex Q2 2021 · Jun 30, 2021 $635K
Capex Q2 2021 · Jun 30, 2020 $1.22M
Operating Cash Flow Q2 2021 · Jun 30, 2021 −$18.04M
Operating Cash Flow restated Q2 2021 · Jun 30, 2020 −$7.07M
Cash And Equivalents Q2 2021 · Jun 30, 2021 $50.01M
Cash And Equivalents Q2 2021 · Dec 31, 2020 $38.75M
Cash And Equivalents restated Q2 2021 · Jun 30, 2020 $5.06M
Cash And Equivalents restated Q2 2021 · Dec 31, 2019 $4.54M
Stockholders Equity Q2 2021 · Jun 30, 2021 $186.17M
Stockholders Equity Q2 2021 · Mar 31, 2021 $144.25M
Stockholders Equity Q2 2021 · Dec 31, 2020 $55.07M
Stockholders Equity restated Q2 2021 · Jun 30, 2020 −$118.59M
Stockholders Equity restated Q2 2021 · Mar 31, 2020 −$108.55M
Stockholders Equity restated Q2 2021 · Dec 31, 2019 −$99.94M
Current Liabilities Q2 2021 · Jun 30, 2021 $20.36M
Current Liabilities Q2 2021 · Dec 31, 2020 $15.94M
Total Liabilities Q2 2021 · Jun 30, 2021 $102.36M
Total Liabilities Q2 2021 · Dec 31, 2020 $29.87M
Current Assets Q2 2021 · Jun 30, 2021 $70.8M
Current Assets Q2 2021 · Dec 31, 2020 $49.08M
Total Assets Q2 2021 · Jun 30, 2021 $288.52M
Total Assets Q2 2021 · Dec 31, 2020 $84.94M
Eps Diluted Q2 2021 · Jun 30, 2021 −$0.16
Eps Diluted Q2 2021 · Jun 30, 2021 −$0.32
Eps Diluted Q2 2021 · Jun 30, 2020 −$0.30
Eps Diluted Q2 2021 · Jun 30, 2020 −$0.55
Eps Basic Q2 2021 · Jun 30, 2021 −$0.16
Eps Basic Q2 2021 · Jun 30, 2021 −$0.32
Eps Basic Q2 2021 · Jun 30, 2020 −$0.30
Eps Basic Q2 2021 · Jun 30, 2020 −$0.55
Sga Expense Q2 2021 · Jun 30, 2021 $22.48M
Sga Expense Q2 2021 · Jun 30, 2021 $43.74M
Sga Expense Q2 2021 · Jun 30, 2020 $9.75M
Sga Expense Q2 2021 · Jun 30, 2020 $18.27M
Net Income Q2 2021 · Jun 30, 2021 −$14.46M
Net Income Q2 2021 · Jun 30, 2021 −$27.05M
Net Income restated Q2 2021 · Jun 30, 2020 −$8.16M
Net Income restated Q2 2021 · Jun 30, 2020 −$15.38M
Operating Income Q2 2021 · Jun 30, 2021 −$11.51M
Operating Income Q2 2021 · Jun 30, 2021 −$27.72M
Operating Income restated Q2 2021 · Jun 30, 2020 −$5.23M
Operating Income restated Q2 2021 · Jun 30, 2020 −$9.66M
Cost Of Revenue Q2 2021 · Jun 30, 2021 $16.94M
Cost Of Revenue Q2 2021 · Jun 30, 2021 $26.7M
Cost Of Revenue Q2 2021 · Jun 30, 2020 $9.03M
Cost Of Revenue Q2 2021 · Jun 30, 2020 $19.74M
Revenue Q2 2021 · Jun 30, 2021 $24.96M
Revenue Q2 2021 · Jun 30, 2021 $39.78M
Revenue Q2 2021 · Jun 30, 2020 $13.55M
Revenue Q2 2021 · Jun 30, 2020 $28.36M